Verastem reported $76.87M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 64.53B 5.59B Mar/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
AstraZeneca USD 26.01B 46M Jun/2026
Curis USD 29.43M 10.69M Jun/2024
Cytokinetics USD 247.21M 868.77M Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
Incyte USD 28.42M 994K Jun/2026
Laboratory Of America USD 5.92B 23.3M Jun/2026
Novartis USD 37.49B 42M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
TG Therapeutics USD 745.14M 499.5M Mar/2026
Verastem USD 76.87M 4.46M Mar/2026